These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2858895)

  • 21. [Evaluation of myocardial relaxation in the treatment of arterial hypertension: vasodilators and beta blockers].
    Gimeno JV; Martín G; Cosín J
    Rev Esp Cardiol; 1985; 38(5):342-7. PubMed ID: 2867585
    [No Abstract]   [Full Text] [Related]  

  • 22. [The beta 2-pseudoselectivity of ISA (intrinsic sympathomimetic action)--consequences for differential therapy with beta-blockers with and without ISA?].
    Werdan K; Reithmann C
    Dtsch Med Wochenschr; 1988 Feb; 113(7):272-4. PubMed ID: 2893724
    [No Abstract]   [Full Text] [Related]  

  • 23. Hypertension and the kidney: implications of the kidney for effective antihypertensive therapy.
    Hollenberg NK
    Medicographia; 1987; 9(3):2-4. PubMed ID: 11539067
    [No Abstract]   [Full Text] [Related]  

  • 24. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA; Schrier RW; Earley LE
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renin and age, determinants of the beta-blocker effect in essential hypertension].
    Bühler FR
    Adv Clin Pharmacol; 1976; 11():42-53. PubMed ID: 25569
    [No Abstract]   [Full Text] [Related]  

  • 26. [Beta blocking agents and arterial hypertension].
    Squadrito G
    G Clin Med; 1979 May; 60(5):347-65. PubMed ID: 39861
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK; Williams GH
    Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
    [No Abstract]   [Full Text] [Related]  

  • 28. [The pharmacodynamic and hypotensive efficacy of proxodolol in an acute drug test on hypertension patients].
    Kukes VG; Starodubtsev AK; Smirnov MV; Petrov IN
    Eksp Klin Farmakol; 1994; 57(3):45-7. PubMed ID: 7914120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-blockers in hypertension. A review.
    Kelly KL
    J Maine Med Assoc; 1976 Nov; 67(11):337-44. PubMed ID: 11263
    [No Abstract]   [Full Text] [Related]  

  • 30. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasodilators, antihypertensive therapy, and the kidney.
    Hollenberg NK
    Circulation; 1987 Jun; 75(6 Pt 2):V39-42. PubMed ID: 2882875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in hemodynamics and renal function during the oral administration of betaxolol].
    Pathe M; Schwartz J
    Therapie; 1985; 40(4):209-12. PubMed ID: 2862715
    [No Abstract]   [Full Text] [Related]  

  • 34. Beta blockers: the extended family.
    Hager WD; Messineo FC; Katz AM
    Adv Intern Med; 1984; 30():201-29. PubMed ID: 6152107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Report on Round Table on renin suppression and the hypotensive action of beta-adrenergic-blocking drugs.
    Clin Sci Mol Med Suppl; 1975 Jun; 2():109s-115s. PubMed ID: 28873
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-blockers and hypertension: carbon copies or a real choice.
    Whipps RG; Fisher ML; Plotnick GD
    Compr Ther; 1984 Sep; 10(9):12-8. PubMed ID: 6149036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hemodynamics in children with primary arterial hypertension in the process of treating them with beta-adrenoblockaders and electrosleep].
    Oskolkova MK; Kupriianova OO
    Vopr Okhr Materin Det; 1979 Jul; 24(7):14-8. PubMed ID: 43024
    [No Abstract]   [Full Text] [Related]  

  • 38. Renin release: beta 1- or beta 2-receptor mediated?
    Vanhees L; Fagard R; Hespel P; Lijnen P; Amery A
    N Engl J Med; 1985 Jan; 312(2):123-4. PubMed ID: 2856891
    [No Abstract]   [Full Text] [Related]  

  • 39. Alpha adrenergic-mediated renin release is prostaglandin-dependent.
    Olson RD; Nies AS; Gerber JG
    J Pharmacol Exp Ther; 1981 Nov; 219(2):321-5. PubMed ID: 6270304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catecholamine-induced renin release in the anesthetized mongrel dog is due to both alpha and beta adrenoceptor stimulation: evidence that only the alpha adrenoceptor component is prostaglandin mediated.
    Olson RD; Nies AS; Gerber JG
    J Pharmacol Exp Ther; 1983 Mar; 224(3):483-8. PubMed ID: 6298402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.